WuXi STA to grab foothold in Europe with planned BMS facility purchase
The acquisition will expand the CDMO's capabilities and capacity to serve European markets
WuXi STA, a subsidiary of WuXi AppTec, has agreed to purchase Bristol Myers Squibb’s (BMS) manufacturing facility in Couvet, Switzerland, making it the Chinese CDMO's first facility in Europe.
The site is a manufacturing facility with commercial-scale production capacity for capsule and tablet dosage forms and was constructed to accommodate future growth.
The companies anticipate completing the transaction by Q2 2021, which will see WuXi STA acquire the Couvet site’s operations and assets, including the plant, equipment, and a workforce with technical capabilities and expertise.
Lou Schmukler, Executive Vice President and President, Global Product Development and Supply, BMS, described the transation as an "important step" in the "ongoing evolution" of its manufacturing network.
He did, however, highlight that Switzerland remains an important strategic location for the company, and that the company will maintain a strong presence in the Neuchâtel area.
According to Dr Minzhang Chen, CEO of WuXi STA, the acquisition will allow WuXi STA to better serve European markets and support its global customers.
Wuxi STA currently has a 45,000 square-foot facility for producing oral solid dosage forms supporting batch sizes ranging from 100 to 500,000 units in Shanghai's Waigaoqiao free trade zone. It also has two commercial plants with 1 billion tablets/year and 100 million capsules/year capacity at its site in Wuxi City.
The Couvet facility will continue to operate as part of BMS’s manufacturing network until the closing of the transaction.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance